Impact of abobotulinumtoxinA on the clinical features of cervical dystonia in routine practice
Introduction: The efficacy and safety of abobotulinumtoxinA in the management of cervical dystonia has been established in randomized, controlled trials that use a selected trial population. In this meta-analysis of observational data, we evaluated the real-life effectiveness of abobotulinumtoxinA a...
Main Authors: | Richard M. Trosch, Vijay P. Misra, Pascal Maisonobe, Savary Om |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-01-01
|
Series: | Clinical Parkinsonism & Related Disorders |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2590112520300311 |
Similar Items
-
Cost-effectiveness analysis of abobotulinumtoxinA for the treatment of cervical dystonia in the United Kingdom
by: Muthukumar M, et al.
Published: (2017-04-01) -
Duration of Symptom Relief Between Injections for AbobotulinumtoxinA (Dysport®) in Spastic Paresis and Cervical Dystonia: Comparison of Evidence From Clinical Studies
by: Alberto Esquenazi, et al.
Published: (2020-09-01) -
Transient Improvement after Switch to Low Doses of RimabotulinumtoxinB in Patients Resistant to AbobotulinumtoxinA
by: Harald Hefter, et al.
Published: (2020-10-01) -
Use of AbobotulinumtoxinA in Adults with Cervical Dystonia: A Systematic Literature Review
by: Alfonso Fasano, et al.
Published: (2020-07-01) -
The Role of Ultrasound for the Personalized Botulinum Toxin Treatment of Cervical Dystonia
by: Urban M. Fietzek, et al.
Published: (2021-05-01)